| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ALTAIR NANOTECHNOLOGIES Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,950 | +1,91 % | Formycon AG: Neuer FYB206-Vermarktungspartner in Asien-Pazifik-Region | Mitteilung der Formycon AG: Lotus Pharmaceutical wird Vermarktungspartner für Formycons Keytruda Biosimilar-Kandidaten FYB206 in weiten Teilen der Asien-Pazifik-Region DieFormycon AG (FWB: FYB, "Formycon")... ► Artikel lesen | |
| ONTO INNOVATION | 187,00 | +1,63 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | ||
| VEECO INSTRUMENTS | 27,400 | +3,01 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| GAUZY | 0,790 | -0,13 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| NANOFORM FINLAND | 0,765 | -1,29 % | Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 | Nanoform Finland Plc | Inside Information | January 07, 2026 at 08:05:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform") starts change negotiations in accordance with the Act on Cooperation.... ► Artikel lesen | |
| SOLESENCE | 1,360 | -6,85 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NVE | 56,50 | +1,80 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| KOPIN | 1,921 | -2,59 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| RIBER | 5,060 | -4,53 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| LAMPETIA | 0,080 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| ZENTEK | 0,530 | -3,64 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,452 | +6,10 % | Fendx Technologies Inc (2): Fendx Technologies issues 32,800 shares for services | ||
| NANOVIRICIDES | 0,850 | +0,59 % | Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| OBDUCAT | 0,003 | +70,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 3,380 | -0,59 % | ACACIA RESEARCH CORP - 8-K, Current Report |